Dr. Robert Driscoll
Recent Articles
Boston Biotech Announces Novartis Collaboration 10/28/2024
Monte Rosa Therapeutics Inc. (GLUE:NASDAQ) recently unveiled a collaborative agreement with Novartis for the development of MRT-6160, its VAV1-degrader program, according to a Wedbush research note.
Pharma Co.'s Partnership a Key Validation 12/04/2023
Recently, Arcus Biosciences Inc. announced a partnership with Exelixis Inc., which may be the key to validating the company, noted WedBush analysts in a December 4 report.
Massachusetts Biotech Advances Novel Cytokine Therapies 11/15/2023
Wedbush sees over 300% upside for Werewolf stock based on early clinical success for its PREDATOR platform and pipeline, according to a WedBush research note.
FDA Approves New Oncology Drug for Clinical Trials 08/28/2023
The first in-human trial of this investigative small molecule is expected to start in Q4/23, noted a Wedbush report.
Due to permission requirements, not all quotes are shown.
